Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 963

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 6
Chunk 963
---
 Unexercised Options Exercisable  (#)  
    Number of Securities Underlying Unexercised Options Unexercisable  (#)  
    Option Exercise Price ($)  
    Option Expiration  Date 
  
    James B. Frakes 
     4/3/2020  
     1,75620(1) 
     –  
     102.40  
     4/2/2030 
  
    Chief Executive Officer and 
     2/10/2022  
     1,253(2) 
     287  
     112.80  
     2/9/2032 
  
    Chief Financial Officer 

    Steven P. LaRosa, M.D. 
     1/4/2021  
     1,512(3) 
     –  
     201.60  
     1/3/2031 
  
    Chief Medical Officer 
     2/10/2022  
     1,253(4) 
     287  
     112.80  
     2/9/2032 

    Guy F. Cipriani, MBA, 
     –  
     –  
     –  
     –  
     – 
  
    Senior Vice President, Chief Operating Officer 
     –  
     –  
     –  
     –  
     – 

    (1)
    This option is subject to vesting at a rate of 25% on the one year anniversary of the grant date of April 3, 2020, then monthly over the following 36 months, subject to Mr. Frakes continued service with the Company.

    (2)
    This option is subject to vesting at a rate of 25% on the one year anniversary of the grant date of February 10, 2022, then monthly over the following 36 months, subject to Mr. Frakes continued service with the Company.

    (3)
    This option is subject to vesting at a rate of 25% on the one year anniversary of the grant date of January 4, 2021, then monthly over the following 36 months, subject to Dr. LaRosa’s continued service with the Company.

    (4)
    This option is subject to vesting at a rate of